Admission Date:  [**2170-1-4**]              Discharge Date:   [**2170-1-14**]  Date of Birth:  [**2106-7-31**]             Sex:   M  Service: MEDICINE  Allergies: Imuran  Attending:[**First Name3 (LF) 2279**] Chief Complaint:  direct admission for cardiac monitoring prior to ERCP/ampullectomy   Major Surgical or Invasive Procedure: Endoscopic Retrograde Cholangiopancreatography [**2170-1-8**]   History of Present Illness: This is a 63 y/o M with CAD s/p MIx2 with late IST in [**2168**] requiring DES in RCA and ESRD on HD (M/W/F) presenting for direct admission for cardiac monitoring prior to ERCP.
Of note patient also undergoing renal transplant evaluation and cannot be placed on transplant list without removal of adenoma.
Patietn was started on plavix at that time and it was discontinued in [**3-/2168**] prior to radical prostatectomy.
He will be able to remain on aspirin per GI.
He denies taking SLNG since his last stent placement on 01/[**2168**].
He last took plavix and aspirin on [**2170-1-3**].
Past Medical History: - Ampullary adenoma with low-grade dysplasia, diagnosed in [**4-/2169**] - Prostate cancer s/p radical prostatectomy in [**3-/2168**] - CAD s/p MI x 2 with DES to RCA in [**2164**] c/b late in-stent thrombosis with DES in RCA in [**12/2168**] after being off plavix since [**3-/2168**] - ESRD on HD M/W/F - may be [**Doctor Last Name **] [**Location (un) **] related however dialysis started in [**2165**] after sustaining contrast-induced nephropathy - HTN - s/p CCY in [**6-/2167**] - Obstructive Sleep Apnea on CPAP   Social History: He is a [**Country 3992**] veteran with a significant exposure to toxics.
He is on disability due to kidney disease.
Family History: significant for skin CA in father and stomach CA in maternal aunt   Physical Exam: Admission Physical Exam: VS: 96.5 150/90 61 16 98% RA GA: AOx3, NAD, appropriate, comfortable HEENT:  PERRLA.
[**1-8**] ampullary mass biopspy: Ampulla, endoscopic mucosal resection:  Focal low-grade dysplasia in a background of acute and chronic inflammation and foveolar metaplasia.
Approximately 5mL of dilute methylene blue/normal saline solution was injected to create a submucosal saline pillow under the ampulla.
An ampullary resection was performed using hot snare cautery in once piece.
Cannulation of the biliary duct was performed with a 5-4-3 catheter using a free-hand technique after ampullectomy.
A straight tip 0.018 inch Roadrunner guidewire was placed into CBD.
A 5cm by 10FR Cotton-[**Doctor Last Name **] biliary stent was placed successfully.
Approximately 6mL of 1:10,000 epinephrine solution was injected and successful hemostasis was accomplished.
Brief Hospital Course: Hospitalization Course 63 y/o M with h/o CAD s/p MI x 2, ESRD on HD, ampullary adenoma here for ERCP and ampullectomy being admitted for plavix washout and close telemetry monitoring given history late in-stent thrombosis whose hospital course was complicated by GI bleed after ERCP/ampullectomy while off plavix.
General [**Hospital **] Hospital Course: [**2170-1-4**] - [**2170-1-10**] Given his history for late in-stent thrombosis, patient was admitted to general medicine wards for cardiac monitoring prior to ERCP/ampullectomy in the setting of stopping plavix.
After the procedure, patient was started on Unasyn for post-procedure infection prophylaxis for a 5 day total course.
He was kept NPO after the procedure to monitor for possible post-ERCP pancreatitis.
On morning of [**2170-1-10**], patient was noted to have large bloody BM in setting of a hypotension.
His vitals remained stable while his second unit of PRBCs was infused and his hematocrit increased.
Once stable, his aspirin was restarted and Cardiology recommended restarting Plavix without a loading dose.
He received hemodialysis twice while in the intensive care unit.
He received a total of 6 units RBCs from the morning of [**1-10**] to the afternoon of [**1-11**].
He is currently on metoprolol tartrate 25mg [**Hospital1 **] instead of his home atenolol and he has not been started on his home Lasix since he is net negative for his LOS so far s/p HD.
He was restarted on plavix (without loading dose, given the bleed, and per Cardiology recommendations) on [**1-14**].
ERCP team felt it was safe to restart plavix on that date.
He was discharged in stable condition on plavix, aspirin, metoprolol (switched from atenolol), protonix (6 week course recommended per ERCP), lasix (restarted at home dose on [**1-14**]), and other chronic home meds (unchanged).
Although there is also that interaction between the protonix and plavix, he needs to remain on protonix for 6 weeks.
He has an appt with ERCP on [**1-24**] for removal of the CBD stent.
Medications on Admission: - Triphrocaps 1 tab daily - Lorazepam 1-2mg Q8h prn: anxiety - Diovan 320mg daily - Fluoxetine 20mg daily - Atenolol 100mg daily - Omeprazole 20mg daily - Oxycodone-Acetominophen 5-325mg daily prn - Furosemide 120mg daily - Phoslo 2668mg TID with meals - Sensipar 30mg QMWF - Plavix 75mg daily - Aspirin 81mg daily - SLNG prn - Simvastatin 40mg QHS  Discharge Medications: 1.
Triphrocaps 1 mg Capsule Sig: One (1) Capsule PO once a day.
2. lorazepam 1 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 hours) as needed for anxiety.
3. valsartan 320 mg Tablet Sig: One (1) Tablet PO once a day.
4. fluoxetine 20 mg Capsule Sig: One (1) Capsule PO DAILY (Daily).
5. oxycodone-acetaminophen 5-325 mg Tablet Sig: One (1) Tablet PO daily as needed for pain.
6. furosemide 40 mg Tablet Sig: Three (3) Tablet PO DAILY (Daily).
7. calcium acetate 667 mg Capsule Sig: Four (4) Capsule PO TID W/MEALS (3 TIMES A DAY WITH MEALS).
8. cinacalcet 30 mg Tablet Sig: One (1) Tablet PO QMOWEFR (Monday -Wednesday-Friday).
9. clopidogrel 75 mg Tablet Sig: One (1) Tablet PO once a day.
10. aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day.
11. simvastatin 40 mg Tablet Sig: One (1) Tablet PO QHS (once a day (at bedtime)).
12. clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
13. pantoprazole 40 mg Tablet, Delayed Release (E.C.)
)(s)* Refills:*0* 14. metoprolol tartrate 25 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Discharge Instructions: You were admitted because you were having a procedure called ERCP to remove a mass in your intestines.
You developed a GI bleed after the procedure, but this stabilized with blood products and did not require further procedures.
You were restarted on aspirin and plavix prior to disharge, with no change in your blood count.
Please note that both fluoxetine and protonix DECREASE the effectiveness of plavix.
The following changes were made to your medications: ---- STOPPED Atenolol ---- STOPPED Omeprazole ---- STARTED Metoprolol 25 mg twice daily ---- STARTED Protonix 40 mg twice daily  No other changes were made to your medications.
Followup Instructions: Please be sure to keep the following appointments:  Name: [**Last Name (LF) 26405**],[**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **] Address: [**Location (un) 26406**], [**Hospital1 **],[**Numeric Identifier 26407**] Phone: [**Telephone/Fax (1) 26408**] Appointment: Thursday, [**1-18**] at 10:30AM  Name: [**Last Name (LF) 26405**],[**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **] Address: [**Location (un) 26406**], [**Hospital1 **],[**Numeric Identifier 26407**] Phone: [**Telephone/Fax (1) 26408**] Appointment: Thursday, [**1-18**] at 10:30AM  Name: [**Last Name (LF) **], [**Name8 (MD) **] MD Location: [**Hospital1 18**]-DIVISION OF GASTROENTEROLOGY/GI EAST Address: [**Location (un) **], [**Hospital Ward Name **] 458, [**Location (un) **],[**Numeric Identifier 718**] Phone: [**Telephone/Fax (1) 2799**] Appointment: [**2170-1-24**], 3:30 pm                                [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) **] MD [**MD Number(2) 2285**]  Completed by:[**2170-1-15**
